Top 5 Cancer Stories
March 2014
 
 
 
 
From DDNews Online:
By Lloyd Dunlap, DDNews Managing Editor
A research team from Imperial College London has shown that blocking the function of an enzyme known as Hhat slows the growth and spread of pancreatic cancer by preventing a protein called Hedgehog from stimulating nearby normal cells to help the cancer
 
From DDNews Online:
By Jeffrey Bouley, DDNews Chief Editor
EMA committee offers positive opinion for Conditional Marketing Authorization of Vynfinit and a Phase 2b vintafolide trial meets primary endpoint of improved progression-free survival
 
From DDNews Daily News:
By Kelsey Kaustinen, DDNews Senior Editor
Companies will develop therapies against targets discovered in two pathways
 
From our March 2014 issue:
By Jeff Inglis, DDNews Contributing Editor
Agreement with Adimab will help discover monoclonal antibodies for cancer immunotherapy
 
From DDNews Daily News:
By Kelsey Kaustinen, DDNews Senior Editor
Companies will seek to determine which tumor types might respond to Tesaro's niraparib
 
 
 
 
   
©2014 Old River Publications LLC. All Rights Reserved.
Web site designed and managed by Offenberger & White, Inc..
If you no longer wish to receive DDNEWS mailings, please unsubscribe here.